$ Value
$72K
Shares
347
Price
$207
Filed
Feb 20
Insider
Name
PREVOZNIK MICHAEL E
Title
SVP & General Counsel
CIK
0001222679
Roles
Transaction Details
Transaction Date
2026-02-18
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
39,482
Footnotes
Represents an award of restricted stock units. | Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. | This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. | These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. | The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.
Filing Info
PREVOZNIK MICHAEL E's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | DGX | ▼ | $800K |
| 2026-03-04 | DGX | A | $1.5M |
| 2026-03-04 | DGX | F | $687K |
| 2026-03-03 | DGX | ▼ | $109K |
| 2026-03-02 | DGX | F | $59K |
| 2026-02-19 | DGX | ▼ | $228K |
| 2026-02-18 | DGX | A | $0 |
| 2026-02-18 | DGX | F | $63K |
| 2026-02-18 | DGX | F | $72K |
| 2026-02-18 | DGX | A | $0 |
Other Insiders at DGX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| CARTER ROBERT B | — | — | 2026-01-28 |
|
PREVOZNIK MICHAEL E
SVP & General Counsel
|
— | $1.1M | 2026-03-05 |
| WENTWORTH TIMOTHY C | — | — | 2026-04-01 |
|
Plewman Patrick
SVP for Diagnostic Services
|
— | $2.0M | 2026-03-05 |
| Gregg Vicky B | — | — | 2026-01-28 |
|
Doherty Catherine T.
EVP, Regional Businesses
|
— | $7.0M | 2026-03-05 |
|
Davis J. E.
CEO and President
|
— | $2.1M | 2026-03-04 |
|
SAMAD SAM
Executive Vice President & CFO
|
— | — | 2026-03-04 |
|
Deppe Michael J
SVP, Corp. Controller & CAO
|
— | — | 2026-03-04 |
| Lassiter Wright III | — | — | 2026-01-28 |
|
KUPPUSAMY KARTHIK
SVP, Clinical Solutions
|
— | $538K | 2026-03-04 |
|
DELANEY MARK E
SVP & Chief Commercial Officer
|
— | — | 2026-03-04 |